Access Bio (XKRX:950130) FCF Yield % : -47.66 (As of May. 28, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Access Bio FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Access Bio's Trailing 12-Month Free Cash Flow is ₩-110,881 Mil, and Market Cap is ₩232,626 Mil. Therefore, Access Bio's FCF Yield % for today is -47.66%.

The historical rank and industry rank for Access Bio's FCF Yield % or its related term are showing as below:

XKRX:950130' s FCF Yield % Range Over the Past 10 Years
Min: -64.28 Med: -3.27 Max: 152.32
Current: -47.66

During the past 12 years, the highest FCF Yield % of Access Bio was 152.32%. The lowest was -64.28%. And the median was -3.27%.

XKRX:950130's FCF Yield % is ranked worse than
82.76% of 232 companies
in the Medical Diagnostics & Research industry
Industry Median: -3.33 vs XKRX:950130: -47.66

Access Bio's FCF Margin % for the quarter that ended in Mar. 2024 was 133.49%.

Access Bio FCF Yield % Historical Data

The historical data trend for Access Bio's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Access Bio FCF Yield % Chart

Access Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-5.73

3.18

22.71

84.54

-40.41

Access Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															46.85	-28.49	-24.72	-149.67	74.33

Competitive Comparison of Access Bio's FCF Yield %

For the Diagnostics & Research subindustry, Access Bio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Access Bio's FCF Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Access Bio's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Access Bio's FCF Yield % falls into.

Access Bio FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Access Bio's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-122555.173	/	303292.743
	=	-40.41%

Access Bio's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	46869.161	*	4	/	252236.774
	=	74.33%

Access Bio FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Access Bio FCF Yield % Related Terms

Thank you for viewing the detailed overview of Access Bio's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Access Bio (XKRX:950130) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Access Bio Inc (XKRX:950130) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Clyde Road, Suite A, Somerset, NJ, USA, 08873

Website

http://www.accessbio.net

Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

Access Bio (XKRX:950130) Headlines

No Headlines